| Pharmacogenomics of cytochrome P450s in Koreans | 2014-02-26 |
| Pharmacokinetic-pharmacodynamic Modeling and Interpretation of Drug-induced QT Prolongation in Early Phase Clinical Trial | 2014-02-13 |
| 2013 KoNSERT Trial KoNSERT: the heart of regional medical industry development Industry Symposium | 2014-02-13 |
| Ethnic Difference and Pharmacogenomics of Asians in Drug Development and Regulation | 2014-02-13 |
| Discovery of cytochrome P450s in human platelets and their potential | 2014-02-13 |
| The development of clinical trial infrastructure in a University hospital and in a regional community: experiences and challenges in Korea | 2014-02-13 |
| Current Situation of Clinical Trials in Korea | 2014-02-13 |
| Drug metabolisms and Transporter: Pharmacogenomics and its current application | 2014-02-13 |
| Clinical validation of genetic biomarkers for antiplatelet drugs in healthy subjects | 2014-02-13 |
| Molecular genetics of cytochrome P450-mediated drug metabolism | 2014-02-13 |
| Translational Pharmacogenomics of Antiplatelet and Anticoagulant for the personalized pharmacotherapy | 2014-02-13 |
| Warfarin Pharmacogenomics from Bench to Bedside | 2014-02-13 |
| Pharmacogenomics of Antiplatelet Clopidogrel for the Personalized Pharmacotherapy | 2014-02-13 |
| Pharmacogenomics based personalized medicine: from discovery to clinical implication | 2014-02-13 |
| Korean Activities to Realize PGx-based Medicine | 2014-02-13 |
| Drug Disposition Pharmacogenetics and Drug Transporters | 2014-02-13 |
| Molecular and Clinical Pharmacogenetics of UGT Enzymes | 2014-02-13 |
| Functional Studies of Human P450 SNPs and Their Clinical Consequences | 2014-02-13 |
| Translation of pharmacogenomics research into clinical practice | 2014-02-13 |
| Genetic and Epigenetic Variation Affecting Cytochrome P450 Expression | 2014-02-13 |
| Pharmacogenomics guided personalized pharmacotherapy: Clinical Pharmacology as a Translator | 2014-02-13 |
| Genetic factors in ethnicity | 2011-03-08 |
| Phase 0 studies including microdosing | 2011-03-08 |
| How close are we to personalized pharmacotherapy based on the pharmacogenomics biomarker? | 2011-03-08 |
| Pharmacogenomics of Antiplatelet and Anticoagulation | 2011-03-08 |
| Investigators perspective | 2011-03-08 |
| The Asian Network for Pharmacogenomics Research(ANPR) to bridge the gap between academic PGx studies and clinical applications | 2011-03-08 |
| Metabolomics for the Prediction of Antihypertensive's Drug Response | 2011-03-08 |
| Genotype guided personalized therapy for increasing drug safety | 2011-03-08 |
| Utilization of pharmacogenomics biomarkers in personalized pharmacotherapy and in clinical trials | 2011-03-08 |